Global Peptide Synthesis Market By Offering (Peptide Synthesizers – Single Channel Peptide Synthesizers, Multi-Channel Peptide Synthesizers, Chromotography Systems, HPLC Columns – Analytical Columns, Prep Columns, Semi-Prep Columns, Lyophilizer/ Freeze Dryers, Peptide Cleavage, Synthesis Reagents – Fmoc-Amino Acids, SPPS Resins, Coupling Reagents for SPPS, DMB and Isoacyl Dipeptides, Others, Others); By Technology (Solid-phase Peptide Synthesis (SPPS) Technology, Liquid-phase Peptide Synthesis (LPPS) Technology, Hybrid Synthesis Technology); By Application (Vaccine Design, Cancer Diagnosis and Treatment, Antibiotic Drug Development, Production of Antibodies, Mass Spectrometry-based Applications, Biological and Drug Discovery Research, Others); By End User (Academic & Research Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Others); By Distribution Channel (Online, Offline); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Global peptide synthesis market was valued at US$ 515 Mn in 2021, growing at an estimated CAGR of 7.5% over the forecast period (2022 – 2030). New medicines and treatments are continuously sought in order to enhance efficacy and bring down costs. Peptides are been seen as a life-saving product and is extensively used in drugs by pharmaceutical companies. Many factors are contributing to the growth of this market. Availability of huge funding has raised the level of research and development activities, along with development of peptide synthesizers that highly automated.
The global peptide synthesis market got a massive in the times of COVID-19 pandemic. Several pharmaceutical and medical research companies turned towards peptide-based drug to battle against the dreadful SARS CoV-2.
Offering Outlook
On the basis of offering, the global peptide synthesis market has been divided into peptide synthesisers, chromatography systems, HPLC columns, lyophilizer/ freezer dryers, peptide cleavage, synthesis reagents and others. While the peptide synthesizers segment is further divided into single channel peptide synthesizers and multi-channel peptide synthesizers, the HPLC columns are divided into analytical columns, prep columns and semi-prep columns. On the other hand, synthesis reagents which generates maximum amount of revenue has been segmented into Fmoc-amino acids, SPPS resins, coupling reagents for SPPS, DMB and Isoacyl dipeptides, and others.
Global Peptide Synthesis Market Revenue & Forecast, (US$ Million), 2022 – 2030
Technology Outlook
The technology segment of the global peptide synthesis market has been segmented into solid-phase peptide synthesis (SPPS) technology, liquid-phase peptide synthesis (LPPS) technology and hybrid synthesis technology. The liquid-phase peptide synthesis (LPPS) technology segment dominates in terms of market share.
Application Outlook
On the basis of application, the global peptide synthesis market has been bifurcated into vaccine design, cancer diagnosis and treatment, antibiotic drug development, production of antibodies, mass spectrometry-based applications, biological and drug discovery research, and others. The number of patients suffering from various types of cancer are on a rise, and peptide-based drugs have proven to be boon for them. This is the reason why; this segment accounts for majority of revenue generated by this market.
End Users Outlook
The end user segment of the global peptide synthesis market has been categorised into academic & research institutions, pharmaceutical and biotechnology companies, contract research organizations (CROs), and others. The contract research organizations (CROs) segment generates most of the money for this market. Several independent research organizations are involved in peptide synthesis, and are ideal solution for existing pharmaceutical companies who want to inculcate peptides into their existing drugs.
Distribution Channel Outlook
The distribution channel of the global peptide synthesis market has been segmented in offline and online. The offline segment brings in maximum amount of revenue for this market, while the online segment is forecasted to witness growth at the fastest rate.
Region Outlook
On the basis of region, the global peptide synthesis market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of North America accounts for most of money minted by this market. Presence of top pharmaceutical companies along with high funding from federal governments for researching peptide-based drugs, help this market grow in the region.
Competitive Landscape
The report provides both, qualitative and quantitative research of global peptide synthesis market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global peptide synthesis market are listed below:
- AAPPTec
- Activotec
- Avenit AG (Bachem)
- Biotage
- Buchi AG
- CEM Corporation
- CSBio
- GenScript
- Merck KGaA
- MP BIOMEDICALS
- Purolite
- Thermo Fisher Scientific
- Other Market Participants
Global Peptide Synthesis Market
By Offering
- Peptide Synthesizers
- Single Channel Peptide Synthesizers
- Multi-Channel Peptide Synthesizers
- Chromatography Systems
- HPLC Columns
- Analytical Columns
- Prep Columns
- Semi-Prep Columns
- Lyophilizer/ Freeze Dryers
- Peptide Cleavage
- Synthesis Reagents
- Fmoc-Amino Acids
- SPPS Resins
- Coupling Reagents for SPPS
- DMB and Isoacyl Dipeptides
- Others
- Others
By Technology
- Solid-phase Peptide Synthesis (SPPS) Technology
- Liquid-phase Peptide Synthesis (LPPS) Technology
- Hybrid Synthesis Technology
By Application
- Vaccine Design
- Cancer Diagnosis and Treatment
- Antibiotic Drug Development
- Production of Antibodies
- Mass Spectrometry-based Applications
- Biological and Drug Discovery Research
- Others
By End Users
- Academic & Research Institutions
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Others
By Distribution Channel
- Online
- Offline
By Region
- North America
- S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2020
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 - 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Peptide Synthesis Market
6. Market Synopsis:
Peptide Synthesis Market
7. Peptide Synthesis Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Peptide Synthesis Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Peptide Synthesis Market
7.6. Porter’s Five Force Analysis
7.7. Impact of
Covid-19 on Peptide Synthesis Market
8. Global Peptide Synthesis Market Analysis and Forecasts, 2022
- 2030
8.1. Overview
8.1.1. Global
Peptide Synthesis Market Revenue (US$ Mn)
8.2. Global
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
8.2.1. Peptide
Synthesizers (Definition, Market Estimation and Penetration, 2015 – 2021,
Market Estimation (2015 – 2021), Market Forecast (2022 - 2030), Compound Annual
Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific,
Middle East and Africa, Latin America) and Information on Single Channel
Peptide Synthesizers, Multi-Channel Peptide Synthesizers)
8.2.1.1. Single
Channel Peptide Synthesizers
8.2.1.2. Multi-Channel
Peptide Synthesizers
8.2.2. Chromatography
Systems
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 – 2021
8.2.2.3. Market
Forecast, 2022 - 2030
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 – 2021
8.2.2.5.1.2. Market
Forecast, 2022 - 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2021
8.2.2.5.2.2. Market
Forecast, 2022 - 2030
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2021
8.2.2.5.3.2. Market
Forecast, 2022 - 2030
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2021
8.2.2.5.4.2. Market
Forecast, 2022 - 2030
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 – 2021
8.2.2.5.5.2. Market
Forecast, 2022 - 2030
8.2.3. HPLC
Columns (Definition, Market Estimation and Penetration, 2015 – 2021, Market
Estimation (2015 – 2021), Market Forecast (2022 - 2030), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Analytical Columns, Prep
Columns, Semi-Prep Columns)
8.2.3.1. Analytical
Columns
8.2.3.2. Prep
Columns
8.2.3.3. Semi-Prep
Columns
8.2.4. Lyophilizer/Freeze
Dryers
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 – 2021
8.2.4.3. Market
Forecast, 2022 - 2030
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market
Estimation, 2015 – 2021
8.2.4.5.1.2. Market
Forecast, 2022 - 2030
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 – 2021
8.2.4.5.2.2. Market
Forecast, 2022 - 2030
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market
Estimation, 2015 – 2021
8.2.4.5.3.2. Market
Forecast, 2022 - 2030
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 – 2021
8.2.4.5.4.2. Market
Forecast, 2022 - 2030
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market
Estimation, 2015 – 2021
8.2.4.5.5.2. Market
Forecast, 2022 - 2030
8.2.5. Peptide
Cleavage
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2015 – 2021
8.2.5.3. Market
Forecast, 2022 - 2030
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market
Estimation, 2015 – 2021
8.2.5.5.1.2. Market
Forecast, 2022 - 2030
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 – 2021
8.2.5.5.2.2. Market
Forecast, 2022 - 2030
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market
Estimation, 2015 – 2021
8.2.5.5.3.2. Market
Forecast, 2022 - 2030
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 – 2021
8.2.5.5.4.2. Market
Forecast, 2022 - 2030
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market
Estimation, 2015 – 2021
8.2.5.5.5.2. Market
Forecast, 2022 - 2030
8.2.6. Synthesis
Reagents (Definition, Market Estimation and Penetration, 2015 – 2021, Market
Estimation (2015 – 2021), Market Forecast (2022 - 2030), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Fmoc-Amino Acids, SPPS
Resins, Coupling Reagents for SPPS, DMB and Isoacyl Dipeptides, Others)
8.2.6.1. Fmoc-Amino
Acids
8.2.6.2. SPPS
Resins
8.2.6.3. Coupling
Reagents for SPPS
8.2.6.4. DMB
and Isoacyl Dipeptides
8.2.6.5. Others
8.2.7. Others
8.2.7.1. Definition
8.2.7.2. Market
Estimation and Penetration, 2015 – 2021
8.2.7.3. Market
Forecast, 2022 - 2030
8.2.7.4. Compound
Annual Growth Rate (CAGR)
8.2.7.5. Regional
Bifurcation
8.2.7.5.1. North
America
8.2.7.5.1.1. Market
Estimation, 2015 – 2021
8.2.7.5.1.2. Market
Forecast, 2022 - 2030
8.2.7.5.2. Europe
8.2.7.5.2.1. Market
Estimation, 2015 – 2021
8.2.7.5.2.2. Market
Forecast, 2022 - 2030
8.2.7.5.3. Asia
Pacific
8.2.7.5.3.1. Market
Estimation, 2015 – 2021
8.2.7.5.3.2. Market
Forecast, 2022 - 2030
8.2.7.5.4. Middle
East and Africa
8.2.7.5.4.1. Market
Estimation, 2015 – 2021
8.2.7.5.4.2. Market
Forecast, 2022 - 2030
8.2.7.5.5. Latin
America
8.2.7.5.5.1. Market
Estimation, 2015 – 2021
8.2.7.5.5.2. Market
Forecast, 2022 - 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offering
9. Global Peptide Synthesis Market Analysis and Forecasts, 2022
- 2030
9.1. Overview
9.2. Global
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
9.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2021
9.2.1.3. Market
Forecast, 2022 - 2030
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2021
9.2.1.5.1.2. Market
Forecast, 2022 - 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2021
9.2.1.5.2.2. Market
Forecast, 2022 - 2030
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2021
9.2.1.5.3.2. Market
Forecast, 2022 - 2030
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2021
9.2.1.5.4.2. Market
Forecast, 2022 - 2030
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2021
9.2.1.5.5.2. Market
Forecast, 2022 - 2030
9.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2021
9.2.2.3. Market
Forecast, 2022 - 2030
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2021
9.2.2.5.1.2. Market
Forecast, 2022 - 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2021
9.2.2.5.2.2. Market
Forecast, 2022 - 2030
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2021
9.2.2.5.3.2. Market
Forecast, 2022 - 2030
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2021
9.2.2.5.4.2. Market
Forecast, 2022 - 2030
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2021
9.2.2.5.5.2. Market
Forecast, 2022 - 2030
9.2.3. Hybrid
Synthesis Technology
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 – 2021
9.2.3.3. Market
Forecast, 2022 - 2030
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 – 2021
9.2.3.5.1.2. Market
Forecast, 2022 - 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 – 2021
9.2.3.5.2.2. Market
Forecast, 2022 - 2030
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 – 2021
9.2.3.5.3.2. Market
Forecast, 2022 - 2030
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 – 2021
9.2.3.5.4.2. Market
Forecast, 2022 - 2030
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 – 2021
9.2.3.5.5.2. Market
Forecast, 2022 - 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
Technology
10. Global Peptide Synthesis Market Analysis and Forecasts, 2022
- 2030
10.1. Overview
10.2. Global
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1. Vaccine
Design
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 – 2021
10.2.1.3. Market
Forecast, 2022 - 2030
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 – 2021
10.2.1.5.1.2. Market
Forecast, 2022 - 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2021
10.2.1.5.2.2. Market
Forecast, 2022 - 2030
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2021
10.2.1.5.3.2. Market
Forecast, 2022 - 2030
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2021
10.2.1.5.4.2. Market
Forecast, 2022 - 2030
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 – 2021
10.2.1.5.5.2. Market
Forecast, 2022 - 2030
10.2.2. Cancer
Diagnosis and Treatment
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 – 2021
10.2.2.3. Market
Forecast, 2022 - 2030
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 – 2021
10.2.2.5.1.2. Market
Forecast, 2022 - 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2021
10.2.2.5.2.2. Market
Forecast, 2022 - 2030
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2021
10.2.2.5.3.2. Market
Forecast, 2022 - 2030
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2021
10.2.2.5.4.2. Market
Forecast, 2022 - 2030
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 – 2021
10.2.2.5.5.2. Market
Forecast, 2022 - 2030
10.2.3. Antibiotic
Drug Development
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 – 2021
10.2.3.3. Market
Forecast, 2022 - 2030
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 – 2021
10.2.3.5.1.2. Market
Forecast, 2022 - 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 – 2021
10.2.3.5.2.2. Market
Forecast, 2022 - 2030
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 – 2021
10.2.3.5.3.2. Market
Forecast, 2022 - 2030
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 – 2021
10.2.3.5.4.2. Market
Forecast, 2022 - 2030
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 – 2021
10.2.3.5.5.2. Market
Forecast, 2022 - 2030
10.2.4. Production
of Antibodies
10.2.4.1. Definition
10.2.4.2. Market
Estimation and Penetration, 2015 – 2021
10.2.4.3. Market
Forecast, 2022 - 2030
10.2.4.4. Compound
Annual Growth Rate (CAGR)
10.2.4.5. Regional
Bifurcation
10.2.4.5.1. North
America
10.2.4.5.1.1. Market
Estimation, 2015 – 2021
10.2.4.5.1.2. Market
Forecast, 2022 - 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 – 2021
10.2.4.5.2.2. Market
Forecast, 2022 - 2030
10.2.4.5.3. Asia
Pacific
10.2.4.5.3.1. Market
Estimation, 2015 – 2021
10.2.4.5.3.2. Market
Forecast, 2022 - 2030
10.2.4.5.4. Middle
East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 – 2021
10.2.4.5.4.2. Market
Forecast, 2022 - 2030
10.2.4.5.5. Latin
America
10.2.4.5.5.1. Market
Estimation, 2015 – 2021
10.2.4.5.5.2. Market
Forecast, 2022 - 2030
10.2.5. Mass
Spectrometry-based Applications
10.2.5.1. Definition
10.2.5.2. Market
Estimation and Penetration, 2015 – 2021
10.2.5.3. Market
Forecast, 2022 - 2030
10.2.5.4. Compound
Annual Growth Rate (CAGR)
10.2.5.5. Regional
Bifurcation
10.2.5.5.1. North
America
10.2.5.5.1.1. Market
Estimation, 2015 – 2021
10.2.5.5.1.2. Market
Forecast, 2022 - 2030
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 – 2021
10.2.5.5.2.2. Market
Forecast, 2022 - 2030
10.2.5.5.3. Asia
Pacific
10.2.5.5.3.1. Market
Estimation, 2015 – 2021
10.2.5.5.3.2. Market
Forecast, 2022 - 2030
10.2.5.5.4. Middle
East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 – 2021
10.2.5.5.4.2. Market
Forecast, 2022 - 2030
10.2.5.5.5. Latin
America
10.2.5.5.5.1. Market
Estimation, 2015 – 2021
10.2.5.5.5.2. Market
Forecast, 2022 - 2030
10.2.6. Biological
and Drug Discovery Research
10.2.6.1. Definition
10.2.6.2. Market
Estimation and Penetration, 2015 – 2021
10.2.6.3. Market
Forecast, 2022 - 2030
10.2.6.4. Compound
Annual Growth Rate (CAGR)
10.2.6.5. Regional
Bifurcation
10.2.6.5.1. North
America
10.2.6.5.1.1. Market
Estimation, 2015 – 2021
10.2.6.5.1.2. Market
Forecast, 2022 - 2030
10.2.6.5.2. Europe
10.2.6.5.2.1. Market
Estimation, 2015 – 2021
10.2.6.5.2.2. Market
Forecast, 2022 - 2030
10.2.6.5.3. Asia
Pacific
10.2.6.5.3.1. Market
Estimation, 2015 – 2021
10.2.6.5.3.2. Market
Forecast, 2022 - 2030
10.2.6.5.4. Middle
East and Africa
10.2.6.5.4.1. Market
Estimation, 2015 – 2021
10.2.6.5.4.2. Market
Forecast, 2022 - 2030
10.2.6.5.5. Latin
America
10.2.6.5.5.1. Market
Estimation, 2015 – 2021
10.2.6.5.5.2. Market
Forecast, 2022 - 2030
10.2.7. Others
10.2.7.1. Definition
10.2.7.2. Market
Estimation and Penetration, 2015 – 2021
10.2.7.3. Market
Forecast, 2022 - 2030
10.2.7.4. Compound
Annual Growth Rate (CAGR)
10.2.7.5. Regional
Bifurcation
10.2.7.5.1. North
America
10.2.7.5.1.1. Market
Estimation, 2015 – 2021
10.2.7.5.1.2. Market
Forecast, 2022 - 2030
10.2.7.5.2. Europe
10.2.7.5.2.1. Market
Estimation, 2015 – 2021
10.2.7.5.2.2. Market
Forecast, 2022 - 2030
10.2.7.5.3. Asia
Pacific
10.2.7.5.3.1. Market
Estimation, 2015 – 2021
10.2.7.5.3.2. Market
Forecast, 2022 - 2030
10.2.7.5.4. Middle
East and Africa
10.2.7.5.4.1. Market
Estimation, 2015 – 2021
10.2.7.5.4.2. Market
Forecast, 2022 - 2030
10.2.7.5.5. Latin
America
10.2.7.5.5.1. Market
Estimation, 2015 – 2021
10.2.7.5.5.2. Market
Forecast, 2022 - 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By
Application
11. Global Peptide Synthesis Market Analysis and Forecasts, 2022
- 2030
11.1. Overview
11.2. Global
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Academic
and Research Institutions
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 – 2021
11.2.1.3. Market
Forecast, 2022 - 2030
11.2.1.4. Compound
Annual Growth Rate (CAGR)
11.2.1.5. Regional
Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 – 2021
11.2.1.5.1.2. Market
Forecast, 2022 - 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 – 2021
11.2.1.5.2.2. Market
Forecast, 2022 - 2030
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 – 2021
11.2.1.5.3.2. Market
Forecast, 2022 - 2030
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 – 2021
11.2.1.5.4.2. Market
Forecast, 2022 - 2030
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 – 2021
11.2.1.5.5.2. Market
Forecast, 2022 - 2030
11.2.2. Pharmaceutical
and Biotechnology Companies
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 – 2021
11.2.2.3. Market
Forecast, 2022 - 2030
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 – 2021
11.2.2.5.1.2. Market
Forecast, 2022 - 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 – 2021
11.2.2.5.2.2. Market
Forecast, 2022 - 2030
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 – 2021
11.2.2.5.3.2. Market
Forecast, 2022 - 2030
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 – 2021
11.2.2.5.4.2. Market
Forecast, 2022 - 2030
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 – 2021
11.2.2.5.5.2. Market
Forecast, 2022 - 2030
11.2.3. Contract
Research Organizations (CROs)
11.2.3.1. Definition
11.2.3.2. Market
Estimation and Penetration, 2015 – 2021
11.2.3.3. Market
Forecast, 2022 - 2030
11.2.3.4. Compound
Annual Growth Rate (CAGR)
11.2.3.5. Regional
Bifurcation
11.2.3.5.1. North
America
11.2.3.5.1.1. Market
Estimation, 2015 – 2021
11.2.3.5.1.2. Market
Forecast, 2022 - 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 – 2021
11.2.3.5.2.2. Market
Forecast, 2022 - 2030
11.2.3.5.3. Asia
Pacific
11.2.3.5.3.1. Market
Estimation, 2015 – 2021
11.2.3.5.3.2. Market
Forecast, 2022 - 2030
11.2.3.5.4. Middle
East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 – 2021
11.2.3.5.4.2. Market
Forecast, 2022 - 2030
11.2.3.5.5. Latin
America
11.2.3.5.5.1. Market
Estimation, 2015 – 2021
11.2.3.5.5.2. Market
Forecast, 2022 - 2030
11.2.4. Others
11.2.4.1. Definition
11.2.4.2. Market
Estimation and Penetration, 2015 – 2021
11.2.4.3. Market
Forecast, 2022 - 2030
11.2.4.4. Compound
Annual Growth Rate (CAGR)
11.2.4.5. Regional
Bifurcation
11.2.4.5.1. North
America
11.2.4.5.1.1. Market
Estimation, 2015 – 2021
11.2.4.5.1.2. Market
Forecast, 2022 - 2030
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 – 2021
11.2.4.5.2.2. Market
Forecast, 2022 - 2030
11.2.4.5.3. Asia
Pacific
11.2.4.5.3.1. Market
Estimation, 2015 – 2021
11.2.4.5.3.2. Market
Forecast, 2022 - 2030
11.2.4.5.4. Middle
East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 – 2021
11.2.4.5.4.2. Market
Forecast, 2022 - 2030
11.2.4.5.5. Latin
America
11.2.4.5.5.1. Market
Estimation, 2015 – 2021
11.2.4.5.5.2. Market
Forecast, 2022 - 2030
11.3. Key
Segment for Channeling Investments
11.3.1. By End
Users
12. Global Peptide Synthesis Market Analysis and Forecasts, 2022
- 2030
12.1. Overview
12.2. Global
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
12.2.1. Online
12.2.1.1. Definition
12.2.1.2. Market
Estimation and Penetration, 2015 – 2021
12.2.1.3. Market
Forecast, 2022 - 2030
12.2.1.4. Compound
Annual Growth Rate (CAGR)
12.2.1.5. Regional
Bifurcation
12.2.1.5.1. North
America
12.2.1.5.1.1. Market
Estimation, 2015 – 2021
12.2.1.5.1.2. Market
Forecast, 2022 - 2030
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 – 2021
12.2.1.5.2.2. Market
Forecast, 2022 - 2030
12.2.1.5.3. Asia
Pacific
12.2.1.5.3.1. Market
Estimation, 2015 – 2021
12.2.1.5.3.2. Market
Forecast, 2022 - 2030
12.2.1.5.4. Middle
East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 – 2021
12.2.1.5.4.2. Market
Forecast, 2022 - 2030
12.2.1.5.5. Latin
America
12.2.1.5.5.1. Market
Estimation, 2015 – 2021
12.2.1.5.5.2. Market
Forecast, 2022 - 2030
12.2.2. Offline
12.2.2.1. Definition
12.2.2.2. Market
Estimation and Penetration, 2015 – 2021
12.2.2.3. Market
Forecast, 2022 - 2030
12.2.2.4. Compound
Annual Growth Rate (CAGR)
12.2.2.5. Regional
Bifurcation
12.2.2.5.1. North
America
12.2.2.5.1.1. Market
Estimation, 2015 – 2021
12.2.2.5.1.2. Market
Forecast, 2022 - 2030
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 – 2021
12.2.2.5.2.2. Market
Forecast, 2022 - 2030
12.2.2.5.3. Asia
Pacific
12.2.2.5.3.1. Market
Estimation, 2015 – 2021
12.2.2.5.3.2. Market
Forecast, 2022 - 2030
12.2.2.5.4. Middle
East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 – 2021
12.2.2.5.4.2. Market
Forecast, 2022 - 2030
12.2.2.5.5. Latin
America
12.2.2.5.5.1. Market
Estimation, 2015 – 2021
12.2.2.5.5.2. Market
Forecast, 2022 - 2030
12.3. Key
Segment for Channeling Investments
12.3.1. By
Distribution Channel
13. North America Peptide Synthesis Market Analysis and
Forecasts, 2022 - 2030
13.1. Overview
13.1.1. North
America Peptide Synthesis Market Revenue (US$ Mn)
13.2. North
America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
13.2.1. Peptide
Synthesizers
13.2.1.1. Single
Channel Peptide Synthesizers
13.2.1.2. Multi-Channel
Peptide Synthesizers
13.2.2. Chromatography
Systems
13.2.3. HPLC
Columns
13.2.3.1. Analytical
Columns
13.2.3.2. Prep
Columns
13.2.3.3. Semi-Prep
Columns
13.2.4. Lyophilizer/Freeze
Dryers
13.2.5. Peptide
Cleavage
13.2.6. Synthesis
Reagents
13.2.6.1. Fmoc-Amino
Acids
13.2.6.2. SPPS
Resins
13.2.6.3. Coupling
Reagents for SPPS
13.2.6.4. DMB
and Isoacyl Dipeptides
13.2.6.5. Others
13.2.7. Others
13.3. North
America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
13.3.1. Solid-phase
Peptide Synthesis (SPPS) Technology
13.3.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
13.3.3. Hybrid
Synthesis Technology
13.4. North
America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
13.4.1. Vaccine
Design
13.4.2. Cancer
Diagnosis and Treatment
13.4.3. Antibiotic
Drug Development
13.4.4. Production
of Antibodies
13.4.5. Mass
Spectrometry-based Applications
13.4.6. Biological
and Drug Discovery Research
13.4.7. Others
13.5. North
America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Academic
and Research Institutions
13.5.2. Pharmaceutical
and Biotechnology Companies
13.5.3. Contract
Research Organizations (CROs)
13.5.4. Others
13.6. North
America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.6.1. Online
13.6.2. Offline
13.7. North
America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1. U.S
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
13.7.1.1.1. Peptide
Synthesizers
13.7.1.1.1.1. Single
Channel Peptide Synthesizers
13.7.1.1.1.2. Multi-Channel
Peptide Synthesizers
13.7.1.1.2. Chromatography
Systems
13.7.1.1.3. HPLC
Columns
13.7.1.1.3.1. Analytical
Columns
13.7.1.1.3.2. Prep
Columns
13.7.1.1.3.3. Semi-Prep
Columns
13.7.1.1.4. Lyophilizer/Freeze
Dryers
13.7.1.1.5. Peptide
Cleavage
13.7.1.1.6. Synthesis
Reagents
13.7.1.1.6.1. Fmoc-Amino
Acids
13.7.1.1.6.2. SPPS
Resins
13.7.1.1.6.3. Coupling
Reagents for SPPS
13.7.1.1.6.4. DMB
and Isoacyl Dipeptides
13.7.1.1.6.5. Others
13.7.1.1.7. Others
13.7.1.2. U.S
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
13.7.1.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
13.7.1.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
13.7.1.2.3. Hybrid
Synthesis Technology
13.7.1.3. U.S
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
13.7.1.3.1. Vaccine
Design
13.7.1.3.2. Cancer
Diagnosis and Treatment
13.7.1.3.3. Antibiotic
Drug Development
13.7.1.3.4. Production
of Antibodies
13.7.1.3.5. Mass
Spectrometry-based Applications
13.7.1.3.6. Biological
and Drug Discovery Research
13.7.1.3.7. Others
13.7.1.4. U.S
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
13.7.1.4.1. Academic
and Research Institutions
13.7.1.4.2. Pharmaceutical
and Biotechnology Companies
13.7.1.4.3. Contract
Research Organizations (CROs)
13.7.1.4.4. Others
13.7.1.5. U.S
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.7.1.5.1. Online
13.7.1.5.2. Offline
13.7.2. Canada
13.7.2.1. Canada
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
13.7.2.1.1. Peptide
Synthesizers
13.7.2.1.1.1. Single
Channel Peptide Synthesizers
13.7.2.1.1.2. Multi-Channel
Peptide Synthesizers
13.7.2.1.2. Chromatography
Systems
13.7.2.1.3. HPLC
Columns
13.7.2.1.3.1. Analytical
Columns
13.7.2.1.3.2. Prep
Columns
13.7.2.1.3.3. Semi-Prep
Columns
13.7.2.1.4. Lyophilizer/Freeze
Dryers
13.7.2.1.5. Peptide
Cleavage
13.7.2.1.6. Synthesis
Reagents
13.7.2.1.6.1. Fmoc-Amino
Acids
13.7.2.1.6.2. SPPS
Resins
13.7.2.1.6.3. Coupling
Reagents for SPPS
13.7.2.1.6.4. DMB
and Isoacyl Dipeptides
13.7.2.1.6.5. Others
13.7.2.1.7. Others
13.7.2.2. Canada
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
13.7.2.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
13.7.2.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
13.7.2.2.3. Hybrid
Synthesis Technology
13.7.2.3. Canada
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
13.7.2.3.1. Vaccine
Design
13.7.2.3.2. Cancer
Diagnosis and Treatment
13.7.2.3.3. Antibiotic
Drug Development
13.7.2.3.4. Production
of Antibodies
13.7.2.3.5. Mass
Spectrometry-based Applications
13.7.2.3.6. Biological
and Drug Discovery Research
13.7.2.3.7. Others
13.7.2.4. Canada
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
13.7.2.4.1. Academic
and Research Institutions
13.7.2.4.2. Pharmaceutical
and Biotechnology Companies
13.7.2.4.3. Contract
Research Organizations (CROs)
13.7.2.4.4. Others
13.7.2.5. Canada
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.7.2.5.1. Online
13.7.2.5.2. Offline
13.7.3. Mexico
13.7.3.1. Mexico
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
13.7.3.1.1. Peptide
Synthesizers
13.7.3.1.1.1. Single
Channel Peptide Synthesizers
13.7.3.1.1.2. Multi-Channel
Peptide Synthesizers
13.7.3.1.2. Chromatography
Systems
13.7.3.1.3. HPLC
Columns
13.7.3.1.3.1. Analytical
Columns
13.7.3.1.3.2. Prep
Columns
13.7.3.1.3.3. Semi-Prep
Columns
13.7.3.1.4. Lyophilizer/Freeze
Dryers
13.7.3.1.5. Peptide
Cleavage
13.7.3.1.6. Synthesis
Reagents
13.7.3.1.6.1. Fmoc-Amino
Acids
13.7.3.1.6.2. SPPS
Resins
13.7.3.1.6.3. Coupling
Reagents for SPPS
13.7.3.1.6.4. DMB
and Isoacyl Dipeptides
13.7.3.1.6.5. Others
13.7.3.1.7. Others
13.7.3.2. Mexico
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
13.7.3.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
13.7.3.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
13.7.3.2.3. Hybrid
Synthesis Technology
13.7.3.3. Mexico
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
13.7.3.3.1. Vaccine
Design
13.7.3.3.2. Cancer
Diagnosis and Treatment
13.7.3.3.3. Antibiotic
Drug Development
13.7.3.3.4. Production
of Antibodies
13.7.3.3.5. Mass
Spectrometry-based Applications
13.7.3.3.6. Biological
and Drug Discovery Research
13.7.3.3.7. Others
13.7.3.4. Mexico
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
13.7.3.4.1. Academic
and Research Institutions
13.7.3.4.2. Pharmaceutical
and Biotechnology Companies
13.7.3.4.3. Contract
Research Organizations (CROs)
13.7.3.4.4. Others
13.7.3.5. Mexico
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.7.3.5.1. Online
13.7.3.5.2. Offline
13.7.4. Rest of
North America
13.7.4.1. Rest
of North America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Offering
13.7.4.1.1. Peptide
Synthesizers
13.7.4.1.1.1. Single
Channel Peptide Synthesizers
13.7.4.1.1.2. Multi-Channel
Peptide Synthesizers
13.7.4.1.2. Chromatography
Systems
13.7.4.1.3. HPLC
Columns
13.7.4.1.3.1. Analytical
Columns
13.7.4.1.3.2. Prep
Columns
13.7.4.1.3.3. Semi-Prep
Columns
13.7.4.1.4. Lyophilizer/Freeze
Dryers
13.7.4.1.5. Peptide
Cleavage
13.7.4.1.6. Synthesis
Reagents
13.7.4.1.6.1. Fmoc-Amino
Acids
13.7.4.1.6.2. SPPS
Resins
13.7.4.1.6.3. Coupling
Reagents for SPPS
13.7.4.1.6.4. DMB
and Isoacyl Dipeptides
13.7.4.1.6.5. Others
13.7.4.1.7. Others
13.7.4.2. Rest
of North America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Technology
13.7.4.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
13.7.4.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
13.7.4.2.3. Hybrid
Synthesis Technology
13.7.4.3. Rest
of North America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.4.3.1. Vaccine
Design
13.7.4.3.2. Cancer
Diagnosis and Treatment
13.7.4.3.3. Antibiotic
Drug Development
13.7.4.3.4. Production
of Antibodies
13.7.4.3.5. Mass
Spectrometry-based Applications
13.7.4.3.6. Biological
and Drug Discovery Research
13.7.4.3.7. Others
13.7.4.4. Rest
of North America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
End Users
13.7.4.4.1. Academic
and Research Institutions
13.7.4.4.2. Pharmaceutical
and Biotechnology Companies
13.7.4.4.3. Contract
Research Organizations (CROs)
13.7.4.4.4. Others
13.7.4.5. Rest
of North America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.7.4.5.1. Online
13.7.4.5.2. Offline
13.8. Key
Segment for Channeling Investments
13.8.1. By
Country
13.8.2. By
Offering
13.8.3. By
Technology
13.8.4. By
Application
13.8.5. By End
Users
13.8.6. By
Distribution Channel
14. Europe Peptide Synthesis Market Analysis and Forecasts, 2022
- 2030
14.1. Overview
14.1.1. Europe
Peptide Synthesis Market Revenue (US$ Mn)
14.2. Europe
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
14.2.1. Peptide
Synthesizers
14.2.1.1. Single
Channel Peptide Synthesizers
14.2.1.2. Multi-Channel
Peptide Synthesizers
14.2.2. Chromatography
Systems
14.2.3. HPLC
Columns
14.2.3.1. Analytical
Columns
14.2.3.2. Prep
Columns
14.2.3.3. Semi-Prep
Columns
14.2.4. Lyophilizer/Freeze
Dryers
14.2.5. Peptide
Cleavage
14.2.6. Synthesis
Reagents
14.2.6.1. Fmoc-Amino
Acids
14.2.6.2. SPPS
Resins
14.2.6.3. Coupling
Reagents for SPPS
14.2.6.4. DMB
and Isoacyl Dipeptides
14.2.6.5. Others
14.2.7. Others
14.3. Europe
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
14.3.1. Solid-phase
Peptide Synthesis (SPPS) Technology
14.3.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
14.3.3. Hybrid
Synthesis Technology
14.4. Europe
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1. Vaccine
Design
14.4.2. Cancer
Diagnosis and Treatment
14.4.3. Antibiotic
Drug Development
14.4.4. Production
of Antibodies
14.4.5. Mass
Spectrometry-based Applications
14.4.6. Biological
and Drug Discovery Research
14.4.7. Others
14.5. Europe
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Academic
and Research Institutions
14.5.2. Pharmaceutical
and Biotechnology Companies
14.5.3. Contract
Research Organizations (CROs)
14.5.4. Others
14.6. Europe
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.6.1. Online
14.6.2. Offline
14.7. Europe
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1. France
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.1.1.1. Peptide
Synthesizers
14.7.1.1.1.1. Single
Channel Peptide Synthesizers
14.7.1.1.1.2. Multi-Channel
Peptide Synthesizers
14.7.1.1.2. Chromatography
Systems
14.7.1.1.3. HPLC
Columns
14.7.1.1.3.1. Analytical
Columns
14.7.1.1.3.2. Prep
Columns
14.7.1.1.3.3. Semi-Prep
Columns
14.7.1.1.4. Lyophilizer/Freeze
Dryers
14.7.1.1.5. Peptide
Cleavage
14.7.1.1.6. Synthesis
Reagents
14.7.1.1.6.1. Fmoc-Amino
Acids
14.7.1.1.6.2. SPPS
Resins
14.7.1.1.6.3. Coupling
Reagents for SPPS
14.7.1.1.6.4. DMB
and Isoacyl Dipeptides
14.7.1.1.6.5. Others
14.7.1.1.7. Others
14.7.1.2. France
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.1.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
14.7.1.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
14.7.1.2.3. Hybrid
Synthesis Technology
14.7.1.3. France
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.1.3.1. Vaccine
Design
14.7.1.3.2. Cancer
Diagnosis and Treatment
14.7.1.3.3. Antibiotic
Drug Development
14.7.1.3.4. Production
of Antibodies
14.7.1.3.5. Mass
Spectrometry-based Applications
14.7.1.3.6. Biological
and Drug Discovery Research
14.7.1.3.7. Others
14.7.1.4. France
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.1.4.1. Academic
and Research Institutions
14.7.1.4.2. Pharmaceutical
and Biotechnology Companies
14.7.1.4.3. Contract
Research Organizations (CROs)
14.7.1.4.4. Others
14.7.1.5. France
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.1.5.1. Online
14.7.1.5.2. Offline
14.7.2. The UK
14.7.2.1. The
UK Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.2.1.1. Peptide
Synthesizers
14.7.2.1.1.1. Single
Channel Peptide Synthesizers
14.7.2.1.1.2. Multi-Channel
Peptide Synthesizers
14.7.2.1.2. Chromatography
Systems
14.7.2.1.3. HPLC
Columns
14.7.2.1.3.1. Analytical
Columns
14.7.2.1.3.2. Prep
Columns
14.7.2.1.3.3. Semi-Prep
Columns
14.7.2.1.4. Lyophilizer/Freeze
Dryers
14.7.2.1.5. Peptide
Cleavage
14.7.2.1.6. Synthesis
Reagents
14.7.2.1.6.1. Fmoc-Amino
Acids
14.7.2.1.6.2. SPPS
Resins
14.7.2.1.6.3. Coupling
Reagents for SPPS
14.7.2.1.6.4. DMB
and Isoacyl Dipeptides
14.7.2.1.6.5. Others
14.7.2.1.7. Others
14.7.2.2. The
UK Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.2.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
14.7.2.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
14.7.2.2.3. Hybrid
Synthesis Technology
14.7.2.3. The
UK Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.2.3.1. Vaccine
Design
14.7.2.3.2. Cancer
Diagnosis and Treatment
14.7.2.3.3. Antibiotic
Drug Development
14.7.2.3.4. Production
of Antibodies
14.7.2.3.5. Mass
Spectrometry-based Applications
14.7.2.3.6. Biological
and Drug Discovery Research
14.7.2.3.7. Others
14.7.2.4. The
UK Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.2.4.1. Academic
and Research Institutions
14.7.2.4.2. Pharmaceutical
and Biotechnology Companies
14.7.2.4.3. Contract
Research Organizations (CROs)
14.7.2.4.4. Others
14.7.2.5. The
UK Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.2.5.1. Online
14.7.2.5.2. Offline
14.7.3. Spain
14.7.3.1. Spain
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.3.1.1. Peptide
Synthesizers
14.7.3.1.1.1. Single
Channel Peptide Synthesizers
14.7.3.1.1.2. Multi-Channel
Peptide Synthesizers
14.7.3.1.2. Chromatography
Systems
14.7.3.1.3. HPLC
Columns
14.7.3.1.3.1. Analytical
Columns
14.7.3.1.3.2. Prep
Columns
14.7.3.1.3.3. Semi-Prep
Columns
14.7.3.1.4. Lyophilizer/Freeze
Dryers
14.7.3.1.5. Peptide
Cleavage
14.7.3.1.6. Synthesis
Reagents
14.7.3.1.6.1. Fmoc-Amino
Acids
14.7.3.1.6.2. SPPS
Resins
14.7.3.1.6.3. Coupling
Reagents for SPPS
14.7.3.1.6.4. DMB
and Isoacyl Dipeptides
14.7.3.1.6.5. Others
14.7.3.1.7. Others
14.7.3.2. Spain
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.3.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
14.7.3.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
14.7.3.2.3. Hybrid
Synthesis Technology
14.7.3.3. Spain
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.3.3.1. Vaccine
Design
14.7.3.3.2. Cancer
Diagnosis and Treatment
14.7.3.3.3. Antibiotic
Drug Development
14.7.3.3.4. Production
of Antibodies
14.7.3.3.5. Mass
Spectrometry-based Applications
14.7.3.3.6. Biological
and Drug Discovery Research
14.7.3.3.7. Others
14.7.3.4. Spain
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.3.4.1. Academic
and Research Institutions
14.7.3.4.2. Pharmaceutical
and Biotechnology Companies
14.7.3.4.3. Contract
Research Organizations (CROs)
14.7.3.4.4. Others
14.7.3.5. Spain
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.3.5.1. Online
14.7.3.5.2. Offline
14.7.4. Germany
14.7.4.1. Germany
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.4.1.1. Peptide
Synthesizers
14.7.4.1.1.1. Single
Channel Peptide Synthesizers
14.7.4.1.1.2. Multi-Channel
Peptide Synthesizers
14.7.4.1.2. Chromatography
Systems
14.7.4.1.3. HPLC
Columns
14.7.4.1.3.1. Analytical
Columns
14.7.4.1.3.2. Prep
Columns
14.7.4.1.3.3. Semi-Prep
Columns
14.7.4.1.4. Lyophilizer/Freeze
Dryers
14.7.4.1.5. Peptide
Cleavage
14.7.4.1.6. Synthesis
Reagents
14.7.4.1.6.1. Fmoc-Amino
Acids
14.7.4.1.6.2. SPPS
Resins
14.7.4.1.6.3. Coupling
Reagents for SPPS
14.7.4.1.6.4. DMB
and Isoacyl Dipeptides
14.7.4.1.6.5. Others
14.7.4.1.7. Others
14.7.4.2. Germany
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.4.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
14.7.4.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
14.7.4.2.3. Hybrid
Synthesis Technology
14.7.4.3. Germany
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.4.3.1. Vaccine
Design
14.7.4.3.2. Cancer
Diagnosis and Treatment
14.7.4.3.3. Antibiotic
Drug Development
14.7.4.3.4. Production
of Antibodies
14.7.4.3.5. Mass
Spectrometry-based Applications
14.7.4.3.6. Biological
and Drug Discovery Research
14.7.4.3.7. Others
14.7.4.4. Germany
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.4.4.1. Academic
and Research Institutions
14.7.4.4.2. Pharmaceutical
and Biotechnology Companies
14.7.4.4.3. Contract
Research Organizations (CROs)
14.7.4.4.4. Others
14.7.4.5. Germany
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.4.5.1. Online
14.7.4.5.2. Offline
14.7.5. Italy
14.7.5.1. Italy
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.5.1.1. Peptide
Synthesizers
14.7.5.1.1.1. Single
Channel Peptide Synthesizers
14.7.5.1.1.2. Multi-Channel
Peptide Synthesizers
14.7.5.1.2. Chromatography
Systems
14.7.5.1.3. HPLC
Columns
14.7.5.1.3.1. Analytical
Columns
14.7.5.1.3.2. Prep
Columns
14.7.5.1.3.3. Semi-Prep
Columns
14.7.5.1.4. Lyophilizer/Freeze
Dryers
14.7.5.1.5. Peptide
Cleavage
14.7.5.1.6. Synthesis
Reagents
14.7.5.1.6.1. Fmoc-Amino
Acids
14.7.5.1.6.2. SPPS
Resins
14.7.5.1.6.3. Coupling
Reagents for SPPS
14.7.5.1.6.4. DMB
and Isoacyl Dipeptides
14.7.5.1.6.5. Others
14.7.5.1.7. Others
14.7.5.2. Italy
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.5.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
14.7.5.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
14.7.5.2.3. Hybrid
Synthesis Technology
14.7.5.3. Italy
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.5.3.1. Vaccine
Design
14.7.5.3.2. Cancer
Diagnosis and Treatment
14.7.5.3.3. Antibiotic
Drug Development
14.7.5.3.4. Production
of Antibodies
14.7.5.3.5. Mass
Spectrometry-based Applications
14.7.5.3.6. Biological
and Drug Discovery Research
14.7.5.3.7. Others
14.7.5.4. Italy
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.5.4.1. Academic
and Research Institutions
14.7.5.4.2. Pharmaceutical
and Biotechnology Companies
14.7.5.4.3. Contract
Research Organizations (CROs)
14.7.5.4.4. Others
14.7.5.5. Italy
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.5.5.1. Online
14.7.5.5.2. Offline
14.7.6. Nordic
Countries
14.7.6.1. Nordic
Countries Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.6.1.1. Peptide
Synthesizers
14.7.6.1.1.1. Single
Channel Peptide Synthesizers
14.7.6.1.1.2. Multi-Channel
Peptide Synthesizers
14.7.6.1.2. Chromatography
Systems
14.7.6.1.3. HPLC
Columns
14.7.6.1.3.1. Analytical
Columns
14.7.6.1.3.2. Prep
Columns
14.7.6.1.3.3. Semi-Prep
Columns
14.7.6.1.4. Lyophilizer/Freeze
Dryers
14.7.6.1.5. Peptide
Cleavage
14.7.6.1.6. Synthesis
Reagents
14.7.6.1.6.1. Fmoc-Amino
Acids
14.7.6.1.6.2. SPPS
Resins
14.7.6.1.6.3. Coupling
Reagents for SPPS
14.7.6.1.6.4. DMB
and Isoacyl Dipeptides
14.7.6.1.6.5. Others
14.7.6.1.7. Others
14.7.6.2. Nordic
Countries Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Technology
14.7.6.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
14.7.6.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
14.7.6.2.3. Hybrid
Synthesis Technology
14.7.6.3. Nordic
Countries Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.6.3.1. Vaccine
Design
14.7.6.3.2. Cancer
Diagnosis and Treatment
14.7.6.3.3. Antibiotic
Drug Development
14.7.6.3.4. Production
of Antibodies
14.7.6.3.5. Mass
Spectrometry-based Applications
14.7.6.3.6. Biological
and Drug Discovery Research
14.7.6.3.7. Others
14.7.6.4. Nordic
Countries Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.6.4.1. Academic
and Research Institutions
14.7.6.4.2. Pharmaceutical
and Biotechnology Companies
14.7.6.4.3. Contract
Research Organizations (CROs)
14.7.6.4.4. Others
14.7.6.5. Nordic
Countries Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.6.5.1. Online
14.7.6.5.2. Offline
14.7.6.6. Nordic
Countries Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux
Union
14.7.7.1. Benelux
Union Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.7.1.1. Peptide
Synthesizers
14.7.7.1.1.1. Single
Channel Peptide Synthesizers
14.7.7.1.1.2. Multi-Channel
Peptide Synthesizers
14.7.7.1.2. Chromatography
Systems
14.7.7.1.3. HPLC
Columns
14.7.7.1.3.1. Analytical
Columns
14.7.7.1.3.2. Prep
Columns
14.7.7.1.3.3. Semi-Prep
Columns
14.7.7.1.4. Lyophilizer/Freeze
Dryers
14.7.7.1.5. Peptide
Cleavage
14.7.7.1.6. Synthesis
Reagents
14.7.7.1.6.1. Fmoc-Amino
Acids
14.7.7.1.6.2. SPPS
Resins
14.7.7.1.6.3. Coupling
Reagents for SPPS
14.7.7.1.6.4. DMB
and Isoacyl Dipeptides
14.7.7.1.6.5. Others
14.7.7.1.7. Others
14.7.7.2. Benelux
Union Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.7.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
14.7.7.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
14.7.7.2.3. Hybrid
Synthesis Technology
14.7.7.3. Benelux
Union Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
14.7.7.3.1. Vaccine
Design
14.7.7.3.2. Cancer
Diagnosis and Treatment
14.7.7.3.3. Antibiotic
Drug Development
14.7.7.3.4. Production
of Antibodies
14.7.7.3.5. Mass
Spectrometry-based Applications
14.7.7.3.6. Biological
and Drug Discovery Research
14.7.7.3.7. Others
14.7.7.4. Benelux
Union Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.7.4.1. Academic
and Research Institutions
14.7.7.4.2. Pharmaceutical
and Biotechnology Companies
14.7.7.4.3. Contract
Research Organizations (CROs)
14.7.7.4.4. Others
14.7.7.5. Benelux
Union Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.7.5.1. Online
14.7.7.5.2. Offline
14.7.7.6. Benelux
Union Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The
Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of
Europe
14.7.8.1. Rest
of Europe Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.8.1.1. Peptide
Synthesizers
14.7.8.1.1.1. Single
Channel Peptide Synthesizers
14.7.8.1.1.2. Multi-Channel
Peptide Synthesizers
14.7.8.1.2. Chromatography
Systems
14.7.8.1.3. HPLC
Columns
14.7.8.1.3.1. Analytical
Columns
14.7.8.1.3.2. Prep
Columns
14.7.8.1.3.3. Semi-Prep
Columns
14.7.8.1.4. Lyophilizer/Freeze
Dryers
14.7.8.1.5. Peptide
Cleavage
14.7.8.1.6. Synthesis
Reagents
14.7.8.1.6.1. Fmoc-Amino
Acids
14.7.8.1.6.2. SPPS
Resins
14.7.8.1.6.3. Coupling
Reagents for SPPS
14.7.8.1.6.4. DMB
and Isoacyl Dipeptides
14.7.8.1.6.5. Others
14.7.8.1.7. Others
14.7.8.2. Rest
of Europe Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Technology
14.7.8.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
14.7.8.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
14.7.8.2.3. Hybrid
Synthesis Technology
14.7.8.3. Rest
of Europe Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.8.3.1. Vaccine
Design
14.7.8.3.2. Cancer
Diagnosis and Treatment
14.7.8.3.3. Antibiotic
Drug Development
14.7.8.3.4. Production
of Antibodies
14.7.8.3.5. Mass
Spectrometry-based Applications
14.7.8.3.6. Biological
and Drug Discovery Research
14.7.8.3.7. Others
14.7.8.4. Rest
of Europe Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.8.4.1. Academic
and Research Institutions
14.7.8.4.2. Pharmaceutical
and Biotechnology Companies
14.7.8.4.3. Contract
Research Organizations (CROs)
14.7.8.4.4. Others
14.7.8.5. Rest
of Europe Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.8.5.1. Online
14.7.8.5.2. Offline
14.8. Key
Segment for Channeling Investments
14.8.1. By
Country
14.8.2. By
Offering
14.8.3. By
Technology
14.8.4. By
Application
14.8.5. By End
Users
14.8.6. By
Distribution Channel
15. Asia Pacific Peptide Synthesis Market Analysis and Forecasts,
2022 - 2030
15.1. Overview
15.1.1. Asia
Pacific Peptide Synthesis Market Revenue (US$ Mn)
15.2. Asia
Pacific Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
15.2.1. Peptide
Synthesizers
15.2.1.1. Single
Channel Peptide Synthesizers
15.2.1.2. Multi-Channel
Peptide Synthesizers
15.2.2. Chromatography
Systems
15.2.3. HPLC
Columns
15.2.3.1. Analytical
Columns
15.2.3.2. Prep
Columns
15.2.3.3. Semi-Prep
Columns
15.2.4. Lyophilizer/Freeze
Dryers
15.2.5. Peptide
Cleavage
15.2.6. Synthesis
Reagents
15.2.6.1. Fmoc-Amino
Acids
15.2.6.2. SPPS
Resins
15.2.6.3. Coupling
Reagents for SPPS
15.2.6.4. DMB
and Isoacyl Dipeptides
15.2.6.5. Others
15.2.7. Others
15.3. Asia
Pacific Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
15.3.1. Solid-phase
Peptide Synthesis (SPPS) Technology
15.3.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
15.3.3. Hybrid
Synthesis Technology
15.4. Asia
Pacific Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
15.4.1. Vaccine
Design
15.4.2. Cancer
Diagnosis and Treatment
15.4.3. Antibiotic
Drug Development
15.4.4. Production
of Antibodies
15.4.5. Mass
Spectrometry-based Applications
15.4.6. Biological
and Drug Discovery Research
15.4.7. Others
15.5. Asia
Pacific Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1. Academic
and Research Institutions
15.5.2. Pharmaceutical
and Biotechnology Companies
15.5.3. Contract
Research Organizations (CROs)
15.5.4. Others
15.6. Asia
Pacific Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.6.1. Online
15.6.2. Offline
15.7. Asia
Pacific Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1. China
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.1.1.1. Peptide
Synthesizers
15.7.1.1.1.1. Single
Channel Peptide Synthesizers
15.7.1.1.1.2. Multi-Channel
Peptide Synthesizers
15.7.1.1.2. Chromatography
Systems
15.7.1.1.3. HPLC
Columns
15.7.1.1.3.1. Analytical
Columns
15.7.1.1.3.2. Prep
Columns
15.7.1.1.3.3. Semi-Prep
Columns
15.7.1.1.4. Lyophilizer/Freeze
Dryers
15.7.1.1.5. Peptide
Cleavage
15.7.1.1.6. Synthesis
Reagents
15.7.1.1.6.1. Fmoc-Amino
Acids
15.7.1.1.6.2. SPPS
Resins
15.7.1.1.6.3. Coupling
Reagents for SPPS
15.7.1.1.6.4. DMB
and Isoacyl Dipeptides
15.7.1.1.6.5. Others
15.7.1.1.7. Others
15.7.1.2. China
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.1.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
15.7.1.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
15.7.1.2.3. Hybrid
Synthesis Technology
15.7.1.3. China
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.1.3.1. Vaccine
Design
15.7.1.3.2. Cancer
Diagnosis and Treatment
15.7.1.3.3. Antibiotic
Drug Development
15.7.1.3.4. Production
of Antibodies
15.7.1.3.5. Mass
Spectrometry-based Applications
15.7.1.3.6. Biological
and Drug Discovery Research
15.7.1.3.7. Others
15.7.1.4. China
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.1.4.1. Academic
and Research Institutions
15.7.1.4.2. Pharmaceutical
and Biotechnology Companies
15.7.1.4.3. Contract
Research Organizations (CROs)
15.7.1.4.4. Others
15.7.1.5. China
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.1.5.1. Online
15.7.1.5.2. Offline
15.7.2. Japan
15.7.2.1. Japan
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.2.1.1. Peptide
Synthesizers
15.7.2.1.1.1. Single
Channel Peptide Synthesizers
15.7.2.1.1.2. Multi-Channel
Peptide Synthesizers
15.7.2.1.2. Chromatography
Systems
15.7.2.1.3. HPLC
Columns
15.7.2.1.3.1. Analytical
Columns
15.7.2.1.3.2. Prep
Columns
15.7.2.1.3.3. Semi-Prep
Columns
15.7.2.1.4. Lyophilizer/Freeze
Dryers
15.7.2.1.5. Peptide
Cleavage
15.7.2.1.6. Synthesis
Reagents
15.7.2.1.6.1. Fmoc-Amino
Acids
15.7.2.1.6.2. SPPS
Resins
15.7.2.1.6.3. Coupling
Reagents for SPPS
15.7.2.1.6.4. DMB
and Isoacyl Dipeptides
15.7.2.1.6.5. Others
15.7.2.1.7. Others
15.7.2.2. Japan
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.2.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
15.7.2.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
15.7.2.2.3. Hybrid
Synthesis Technology
15.7.2.3. Japan
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.2.3.1. Vaccine
Design
15.7.2.3.2. Cancer
Diagnosis and Treatment
15.7.2.3.3. Antibiotic
Drug Development
15.7.2.3.4. Production
of Antibodies
15.7.2.3.5. Mass
Spectrometry-based Applications
15.7.2.3.6. Biological
and Drug Discovery Research
15.7.2.3.7. Others
15.7.2.4. Japan
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.2.4.1. Academic
and Research Institutions
15.7.2.4.2. Pharmaceutical
and Biotechnology Companies
15.7.2.4.3. Contract
Research Organizations (CROs)
15.7.2.4.4. Others
15.7.2.5. Japan
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.2.5.1. Online
15.7.2.5.2. Offline
15.7.3. India
15.7.3.1. India
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.3.1.1. Peptide
Synthesizers
15.7.3.1.1.1. Single
Channel Peptide Synthesizers
15.7.3.1.1.2. Multi-Channel
Peptide Synthesizers
15.7.3.1.2. Chromatography
Systems
15.7.3.1.3. HPLC
Columns
15.7.3.1.3.1. Analytical
Columns
15.7.3.1.3.2. Prep
Columns
15.7.3.1.3.3. Semi-Prep
Columns
15.7.3.1.4. Lyophilizer/Freeze
Dryers
15.7.3.1.5. Peptide
Cleavage
15.7.3.1.6. Synthesis
Reagents
15.7.3.1.6.1. Fmoc-Amino
Acids
15.7.3.1.6.2. SPPS
Resins
15.7.3.1.6.3. Coupling
Reagents for SPPS
15.7.3.1.6.4. DMB
and Isoacyl Dipeptides
15.7.3.1.6.5. Others
15.7.3.1.7. Others
15.7.3.2. India
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.3.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
15.7.3.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
15.7.3.2.3. Hybrid
Synthesis Technology
15.7.3.3. India
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.3.3.1. Vaccine
Design
15.7.3.3.2. Cancer
Diagnosis and Treatment
15.7.3.3.3. Antibiotic
Drug Development
15.7.3.3.4. Production
of Antibodies
15.7.3.3.5. Mass
Spectrometry-based Applications
15.7.3.3.6. Biological
and Drug Discovery Research
15.7.3.3.7. Others
15.7.3.4. India
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.3.4.1. Academic
and Research Institutions
15.7.3.4.2. Pharmaceutical
and Biotechnology Companies
15.7.3.4.3. Contract
Research Organizations (CROs)
15.7.3.4.4. Others
15.7.3.5. India
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.3.5.1. Online
15.7.3.5.2. Offline
15.7.4. New
Zealand
15.7.4.1. New
Zealand Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.4.1.1. Peptide
Synthesizers
15.7.4.1.1.1. Single
Channel Peptide Synthesizers
15.7.4.1.1.2. Multi-Channel
Peptide Synthesizers
15.7.4.1.2. Chromatography
Systems
15.7.4.1.3. HPLC
Columns
15.7.4.1.3.1. Analytical
Columns
15.7.4.1.3.2. Prep
Columns
15.7.4.1.3.3. Semi-Prep
Columns
15.7.4.1.4. Lyophilizer/Freeze
Dryers
15.7.4.1.5. Peptide
Cleavage
15.7.4.1.6. Synthesis
Reagents
15.7.4.1.6.1. Fmoc-Amino
Acids
15.7.4.1.6.2. SPPS
Resins
15.7.4.1.6.3. Coupling
Reagents for SPPS
15.7.4.1.6.4. DMB
and Isoacyl Dipeptides
15.7.4.1.6.5. Others
15.7.4.1.7. Others
15.7.4.2. New
Zealand Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.4.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
15.7.4.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
15.7.4.2.3. Hybrid
Synthesis Technology
15.7.4.3. New
Zealand Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.4.3.1. Vaccine
Design
15.7.4.3.2. Cancer
Diagnosis and Treatment
15.7.4.3.3. Antibiotic
Drug Development
15.7.4.3.4. Production
of Antibodies
15.7.4.3.5. Mass
Spectrometry-based Applications
15.7.4.3.6. Biological
and Drug Discovery Research
15.7.4.3.7. Others
15.7.4.4. New
Zealand Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.4.4.1. Academic
and Research Institutions
15.7.4.4.2. Pharmaceutical
and Biotechnology Companies
15.7.4.4.3. Contract
Research Organizations (CROs)
15.7.4.4.4. Others
15.7.4.5. New
Zealand Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.4.5.1. Online
15.7.4.5.2. Offline
15.7.5. Australia
15.7.5.1. Australia
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.5.1.1. Peptide
Synthesizers
15.7.5.1.1.1. Single
Channel Peptide Synthesizers
15.7.5.1.1.2. Multi-Channel
Peptide Synthesizers
15.7.5.1.2. Chromatography
Systems
15.7.5.1.3. HPLC
Columns
15.7.5.1.3.1. Analytical
Columns
15.7.5.1.3.2. Prep
Columns
15.7.5.1.3.3. Semi-Prep
Columns
15.7.5.1.4. Lyophilizer/Freeze
Dryers
15.7.5.1.5. Peptide
Cleavage
15.7.5.1.6. Synthesis
Reagents
15.7.5.1.6.1. Fmoc-Amino
Acids
15.7.5.1.6.2. SPPS
Resins
15.7.5.1.6.3. Coupling
Reagents for SPPS
15.7.5.1.6.4. DMB
and Isoacyl Dipeptides
15.7.5.1.6.5. Others
15.7.5.1.7. Others
15.7.5.2. Australia
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.5.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
15.7.5.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
15.7.5.2.3. Hybrid
Synthesis Technology
15.7.5.3. Australia
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.5.3.1. Vaccine
Design
15.7.5.3.2. Cancer
Diagnosis and Treatment
15.7.5.3.3. Antibiotic
Drug Development
15.7.5.3.4. Production
of Antibodies
15.7.5.3.5. Mass
Spectrometry-based Applications
15.7.5.3.6. Biological
and Drug Discovery Research
15.7.5.3.7. Others
15.7.5.4. Australia
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.5.4.1. Academic
and Research Institutions
15.7.5.4.2. Pharmaceutical
and Biotechnology Companies
15.7.5.4.3. Contract
Research Organizations (CROs)
15.7.5.4.4. Others
15.7.5.5. Australia
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.5.5.1. Online
15.7.5.5.2. Offline
15.7.6. South
Korea
15.7.6.1. South
Korea Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.6.1.1. Peptide
Synthesizers
15.7.6.1.1.1. Single
Channel Peptide Synthesizers
15.7.6.1.1.2. Multi-Channel
Peptide Synthesizers
15.7.6.1.2. Chromatography
Systems
15.7.6.1.3. HPLC
Columns
15.7.6.1.3.1. Analytical
Columns
15.7.6.1.3.2. Prep
Columns
15.7.6.1.3.3. Semi-Prep
Columns
15.7.6.1.4. Lyophilizer/Freeze
Dryers
15.7.6.1.5. Peptide
Cleavage
15.7.6.1.6. Synthesis
Reagents
15.7.6.1.6.1. Fmoc-Amino
Acids
15.7.6.1.6.2. SPPS
Resins
15.7.6.1.6.3. Coupling
Reagents for SPPS
15.7.6.1.6.4. DMB
and Isoacyl Dipeptides
15.7.6.1.6.5. Others
15.7.6.1.7. Others
15.7.6.2. South
Korea Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.6.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
15.7.6.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
15.7.6.2.3. Hybrid
Synthesis Technology
15.7.6.3. South
Korea Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.6.3.1. Vaccine
Design
15.7.6.3.2. Cancer
Diagnosis and Treatment
15.7.6.3.3. Antibiotic
Drug Development
15.7.6.3.4. Production
of Antibodies
15.7.6.3.5. Mass
Spectrometry-based Applications
15.7.6.3.6. Biological
and Drug Discovery Research
15.7.6.3.7. Others
15.7.6.4. South
Korea Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.6.4.1. Academic
and Research Institutions
15.7.6.4.2. Pharmaceutical
and Biotechnology Companies
15.7.6.4.3. Contract
Research Organizations (CROs)
15.7.6.4.4. Others
15.7.6.5. South
Korea Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.6.5.1. Online
15.7.6.5.2. Offline
15.7.7. Southeast
Asia
15.7.7.1. Southeast
Asia Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.7.1.1. Peptide
Synthesizers
15.7.7.1.1.1. Single
Channel Peptide Synthesizers
15.7.7.1.1.2. Multi-Channel
Peptide Synthesizers
15.7.7.1.2. Chromatography
Systems
15.7.7.1.3. HPLC
Columns
15.7.7.1.3.1. Analytical
Columns
15.7.7.1.3.2. Prep
Columns
15.7.7.1.3.3. Semi-Prep
Columns
15.7.7.1.4. Lyophilizer/Freeze
Dryers
15.7.7.1.5. Peptide
Cleavage
15.7.7.1.6. Synthesis
Reagents
15.7.7.1.6.1. Fmoc-Amino
Acids
15.7.7.1.6.2. SPPS
Resins
15.7.7.1.6.3. Coupling
Reagents for SPPS
15.7.7.1.6.4. DMB
and Isoacyl Dipeptides
15.7.7.1.6.5. Others
15.7.7.1.7. Others
15.7.7.2. Southeast
Asia Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.7.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
15.7.7.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
15.7.7.2.3. Hybrid
Synthesis Technology
15.7.7.3. Southeast
Asia Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
15.7.7.3.1. Vaccine
Design
15.7.7.3.2. Cancer
Diagnosis and Treatment
15.7.7.3.3. Antibiotic
Drug Development
15.7.7.3.4. Production
of Antibodies
15.7.7.3.5. Mass
Spectrometry-based Applications
15.7.7.3.6. Biological
and Drug Discovery Research
15.7.7.3.7. Others
15.7.7.4. Southeast
Asia Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.7.4.1. Academic
and Research Institutions
15.7.7.4.2. Pharmaceutical
and Biotechnology Companies
15.7.7.4.3. Contract
Research Organizations (CROs)
15.7.7.4.4. Others
15.7.7.5. Southeast
Asia Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.7.5.1. Online
15.7.7.5.2. Offline
15.7.7.6. Southeast
Asia Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest
of Southeast Asia
15.7.8. Rest of
Asia Pacific
15.7.8.1. Rest
of Asia Pacific Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Offering
15.7.8.1.1. Peptide
Synthesizers
15.7.8.1.1.1. Single
Channel Peptide Synthesizers
15.7.8.1.1.2. Multi-Channel
Peptide Synthesizers
15.7.8.1.2. Chromatography
Systems
15.7.8.1.3. HPLC
Columns
15.7.8.1.3.1. Analytical
Columns
15.7.8.1.3.2. Prep
Columns
15.7.8.1.3.3. Semi-Prep
Columns
15.7.8.1.4. Lyophilizer/Freeze
Dryers
15.7.8.1.5. Peptide
Cleavage
15.7.8.1.6. Synthesis
Reagents
15.7.8.1.6.1. Fmoc-Amino
Acids
15.7.8.1.6.2. SPPS
Resins
15.7.8.1.6.3. Coupling
Reagents for SPPS
15.7.8.1.6.4. DMB
and Isoacyl Dipeptides
15.7.8.1.6.5. Others
15.7.8.1.7. Others
15.7.8.2. Rest
of Asia Pacific Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Technology
15.7.8.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
15.7.8.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
15.7.8.2.3. Hybrid
Synthesis Technology
15.7.8.3. Rest
of Asia Pacific Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.8.3.1. Vaccine
Design
15.7.8.3.2. Cancer
Diagnosis and Treatment
15.7.8.3.3. Antibiotic
Drug Development
15.7.8.3.4. Production
of Antibodies
15.7.8.3.5. Mass
Spectrometry-based Applications
15.7.8.3.6. Biological
and Drug Discovery Research
15.7.8.3.7. Others
15.7.8.4. Rest
of Asia Pacific Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End
Users
15.7.8.4.1. Academic
and Research Institutions
15.7.8.4.2. Pharmaceutical
and Biotechnology Companies
15.7.8.4.3. Contract
Research Organizations (CROs)
15.7.8.4.4. Others
15.7.8.5. Rest
of Asia Pacific Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.8.5.1. Online
15.7.8.5.2. Offline
15.8. Key Segment
for Channeling Investments
15.8.1. By
Country
15.8.2. By
Offering
15.8.3. By
Technology
15.8.4. By
Application
15.8.5. By End
Users
15.8.6. By
Distribution Channel
16. Middle East and Africa Peptide Synthesis Market Analysis and
Forecasts, 2022 - 2030
16.1. Overview
16.1.1. Middle
East and Africa Peptide Synthesis Market Revenue (US$ Mn)
16.2. Middle
East and Africa Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Offering
16.2.1. Peptide
Synthesizers
16.2.1.1. Single
Channel Peptide Synthesizers
16.2.1.2. Multi-Channel
Peptide Synthesizers
16.2.2. Chromatography
Systems
16.2.3. HPLC
Columns
16.2.3.1. Analytical
Columns
16.2.3.2. Prep
Columns
16.2.3.3. Semi-Prep
Columns
16.2.4. Lyophilizer/Freeze
Dryers
16.2.5. Peptide
Cleavage
16.2.6. Synthesis
Reagents
16.2.6.1. Fmoc-Amino
Acids
16.2.6.2. SPPS
Resins
16.2.6.3. Coupling
Reagents for SPPS
16.2.6.4. DMB
and Isoacyl Dipeptides
16.2.6.5. Others
16.2.7. Others
16.3. Middle
East and Africa Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Technology
16.3.1. Solid-phase
Peptide Synthesis (SPPS) Technology
16.3.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
16.3.3. Hybrid
Synthesis Technology
16.4. Middle
East and Africa Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Application
16.4.1. Vaccine
Design
16.4.2. Cancer
Diagnosis and Treatment
16.4.3. Antibiotic
Drug Development
16.4.4. Production
of Antibodies
16.4.5. Mass
Spectrometry-based Applications
16.4.6. Biological
and Drug Discovery Research
16.4.7. Others
16.5. Middle
East and Africa Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End
Users
16.5.1. Academic
and Research Institutions
16.5.2. Pharmaceutical
and Biotechnology Companies
16.5.3. Contract
Research Organizations (CROs)
16.5.4. Others
16.6. Middle
East and Africa Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.6.1. Online
16.6.2. Offline
16.7. Middle
East and Africa Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Country
16.7.1. Saudi
Arabia
16.7.1.1. Saudi
Arabia Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
16.7.1.1.1. Peptide
Synthesizers
16.7.1.1.1.1. Single
Channel Peptide Synthesizers
16.7.1.1.1.2. Multi-Channel
Peptide Synthesizers
16.7.1.1.2. Chromatography
Systems
16.7.1.1.3. HPLC
Columns
16.7.1.1.3.1. Analytical
Columns
16.7.1.1.3.2. Prep
Columns
16.7.1.1.3.3. Semi-Prep
Columns
16.7.1.1.4. Lyophilizer/Freeze
Dryers
16.7.1.1.5. Peptide
Cleavage
16.7.1.1.6. Synthesis
Reagents
16.7.1.1.6.1. Fmoc-Amino
Acids
16.7.1.1.6.2. SPPS
Resins
16.7.1.1.6.3. Coupling
Reagents for SPPS
16.7.1.1.6.4. DMB
and Isoacyl Dipeptides
16.7.1.1.6.5. Others
16.7.1.1.7. Others
16.7.1.2. Saudi
Arabia Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.1.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
16.7.1.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
16.7.1.2.3. Hybrid
Synthesis Technology
16.7.1.3. Saudi
Arabia Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
16.7.1.3.1. Vaccine
Design
16.7.1.3.2. Cancer
Diagnosis and Treatment
16.7.1.3.3. Antibiotic
Drug Development
16.7.1.3.4. Production
of Antibodies
16.7.1.3.5. Mass
Spectrometry-based Applications
16.7.1.3.6. Biological
and Drug Discovery Research
16.7.1.3.7. Others
16.7.1.4. Saudi
Arabia Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
16.7.1.4.1. Academic
and Research Institutions
16.7.1.4.2. Pharmaceutical
and Biotechnology Companies
16.7.1.4.3. Contract
Research Organizations (CROs)
16.7.1.4.4. Others
16.7.1.5. Saudi
Arabia Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.7.1.5.1. Online
16.7.1.5.2. Offline
16.7.2. UAE
16.7.2.1. UAE
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
16.7.2.1.1. Peptide
Synthesizers
16.7.2.1.1.1. Single
Channel Peptide Synthesizers
16.7.2.1.1.2. Multi-Channel
Peptide Synthesizers
16.7.2.1.2. Chromatography
Systems
16.7.2.1.3. HPLC
Columns
16.7.2.1.3.1. Analytical
Columns
16.7.2.1.3.2. Prep
Columns
16.7.2.1.3.3. Semi-Prep
Columns
16.7.2.1.4. Lyophilizer/Freeze
Dryers
16.7.2.1.5. Peptide
Cleavage
16.7.2.1.6. Synthesis
Reagents
16.7.2.1.6.1. Fmoc-Amino
Acids
16.7.2.1.6.2. SPPS
Resins
16.7.2.1.6.3. Coupling
Reagents for SPPS
16.7.2.1.6.4. DMB
and Isoacyl Dipeptides
16.7.2.1.6.5. Others
16.7.2.1.7. Others
16.7.2.2. UAE
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.2.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
16.7.2.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
16.7.2.2.3. Hybrid
Synthesis Technology
16.7.2.3. UAE
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
16.7.2.3.1. Vaccine
Design
16.7.2.3.2. Cancer
Diagnosis and Treatment
16.7.2.3.3. Antibiotic
Drug Development
16.7.2.3.4. Production
of Antibodies
16.7.2.3.5. Mass
Spectrometry-based Applications
16.7.2.3.6. Biological
and Drug Discovery Research
16.7.2.3.7. Others
16.7.2.4. UAE
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
16.7.2.4.1. Academic
and Research Institutions
16.7.2.4.2. Pharmaceutical
and Biotechnology Companies
16.7.2.4.3. Contract
Research Organizations (CROs)
16.7.2.4.4. Others
16.7.2.5. UAE
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.7.2.5.1. Online
16.7.2.5.2. Offline
16.7.3. Egypt
16.7.3.1. Egypt
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
16.7.3.1.1. Peptide
Synthesizers
16.7.3.1.1.1. Single
Channel Peptide Synthesizers
16.7.3.1.1.2. Multi-Channel
Peptide Synthesizers
16.7.3.1.2. Chromatography
Systems
16.7.3.1.3. HPLC
Columns
16.7.3.1.3.1. Analytical
Columns
16.7.3.1.3.2. Prep
Columns
16.7.3.1.3.3. Semi-Prep
Columns
16.7.3.1.4. Lyophilizer/Freeze
Dryers
16.7.3.1.5. Peptide
Cleavage
16.7.3.1.6. Synthesis
Reagents
16.7.3.1.6.1. Fmoc-Amino
Acids
16.7.3.1.6.2. SPPS
Resins
16.7.3.1.6.3. Coupling
Reagents for SPPS
16.7.3.1.6.4. DMB
and Isoacyl Dipeptides
16.7.3.1.6.5. Others
16.7.3.1.7. Others
16.7.3.2. Egypt
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.3.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
16.7.3.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
16.7.3.2.3. Hybrid
Synthesis Technology
16.7.3.3. Egypt
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
16.7.3.3.1. Vaccine
Design
16.7.3.3.2. Cancer
Diagnosis and Treatment
16.7.3.3.3. Antibiotic
Drug Development
16.7.3.3.4. Production
of Antibodies
16.7.3.3.5. Mass
Spectrometry-based Applications
16.7.3.3.6. Biological
and Drug Discovery Research
16.7.3.3.7. Others
16.7.3.4. Egypt
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
16.7.3.4.1. Academic
and Research Institutions
16.7.3.4.2. Pharmaceutical
and Biotechnology Companies
16.7.3.4.3. Contract
Research Organizations (CROs)
16.7.3.4.4. Others
16.7.3.5. Egypt
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.7.3.5.1. Online
16.7.3.5.2. Offline
16.7.4. Kuwait
16.7.4.1. Kuwait
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
16.7.4.1.1. Peptide
Synthesizers
16.7.4.1.1.1. Single
Channel Peptide Synthesizers
16.7.4.1.1.2. Multi-Channel
Peptide Synthesizers
16.7.4.1.2. Chromatography
Systems
16.7.4.1.3. HPLC
Columns
16.7.4.1.3.1. Analytical
Columns
16.7.4.1.3.2. Prep
Columns
16.7.4.1.3.3. Semi-Prep
Columns
16.7.4.1.4. Lyophilizer/Freeze
Dryers
16.7.4.1.5. Peptide
Cleavage
16.7.4.1.6. Synthesis
Reagents
16.7.4.1.6.1. Fmoc-Amino
Acids
16.7.4.1.6.2. SPPS
Resins
16.7.4.1.6.3. Coupling
Reagents for SPPS
16.7.4.1.6.4. DMB
and Isoacyl Dipeptides
16.7.4.1.6.5. Others
16.7.4.1.7. Others
16.7.4.2. Kuwait
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.4.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
16.7.4.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
16.7.4.2.3. Hybrid
Synthesis Technology
16.7.4.3. Kuwait
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
16.7.4.3.1. Vaccine
Design
16.7.4.3.2. Cancer
Diagnosis and Treatment
16.7.4.3.3. Antibiotic
Drug Development
16.7.4.3.4. Production
of Antibodies
16.7.4.3.5. Mass
Spectrometry-based Applications
16.7.4.3.6. Biological
and Drug Discovery Research
16.7.4.3.7. Others
16.7.4.4. Kuwait
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
16.7.4.4.1. Academic
and Research Institutions
16.7.4.4.2. Pharmaceutical
and Biotechnology Companies
16.7.4.4.3. Contract
Research Organizations (CROs)
16.7.4.4.4. Others
16.7.4.5. Kuwait
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.7.4.5.1. Online
16.7.4.5.2. Offline
16.7.5. South
Africa
16.7.5.1. South
Africa Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
16.7.5.1.1. Peptide
Synthesizers
16.7.5.1.1.1. Single
Channel Peptide Synthesizers
16.7.5.1.1.2. Multi-Channel
Peptide Synthesizers
16.7.5.1.2. Chromatography
Systems
16.7.5.1.3. HPLC
Columns
16.7.5.1.3.1. Analytical
Columns
16.7.5.1.3.2. Prep
Columns
16.7.5.1.3.3. Semi-Prep
Columns
16.7.5.1.4. Lyophilizer/Freeze
Dryers
16.7.5.1.5. Peptide
Cleavage
16.7.5.1.6. Synthesis
Reagents
16.7.5.1.6.1. Fmoc-Amino
Acids
16.7.5.1.6.2. SPPS
Resins
16.7.5.1.6.3. Coupling
Reagents for SPPS
16.7.5.1.6.4. DMB
and Isoacyl Dipeptides
16.7.5.1.6.5. Others
16.7.5.1.7. Others
16.7.5.2. South
Africa Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.5.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
16.7.5.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
16.7.5.2.3. Hybrid
Synthesis Technology
16.7.5.3. South
Africa Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
16.7.5.3.1. Vaccine
Design
16.7.5.3.2. Cancer
Diagnosis and Treatment
16.7.5.3.3. Antibiotic
Drug Development
16.7.5.3.4. Production
of Antibodies
16.7.5.3.5. Mass
Spectrometry-based Applications
16.7.5.3.6. Biological
and Drug Discovery Research
16.7.5.3.7. Others
16.7.5.4. South
Africa Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
16.7.5.4.1. Academic
and Research Institutions
16.7.5.4.2. Pharmaceutical
and Biotechnology Companies
16.7.5.4.3. Contract
Research Organizations (CROs)
16.7.5.4.4. Others
16.7.5.5. South
Africa Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.7.5.5.1. Online
16.7.5.5.2. Offline
16.7.6. Rest of
Middle East & Africa
16.7.6.1. Rest
of Middle East & Africa Peptide Synthesis Market Revenue (US$ Mn) and
Forecasts, By Offering
16.7.6.1.1. Peptide
Synthesizers
16.7.6.1.1.1. Single
Channel Peptide Synthesizers
16.7.6.1.1.2. Multi-Channel
Peptide Synthesizers
16.7.6.1.2. Chromatography
Systems
16.7.6.1.3. HPLC
Columns
16.7.6.1.3.1. Analytical
Columns
16.7.6.1.3.2. Prep
Columns
16.7.6.1.3.3. Semi-Prep
Columns
16.7.6.1.4. Lyophilizer/Freeze
Dryers
16.7.6.1.5. Peptide
Cleavage
16.7.6.1.6. Synthesis
Reagents
16.7.6.1.6.1. Fmoc-Amino
Acids
16.7.6.1.6.2. SPPS
Resins
16.7.6.1.6.3. Coupling
Reagents for SPPS
16.7.6.1.6.4. DMB
and Isoacyl Dipeptides
16.7.6.1.6.5. Others
16.7.6.1.7. Others
16.7.6.2. Rest
of Middle East & Africa Peptide Synthesis Market Revenue (US$ Mn) and
Forecasts, By Technology
16.7.6.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
16.7.6.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
16.7.6.2.3. Hybrid
Synthesis Technology
16.7.6.3. Rest
of Middle East & Africa Peptide Synthesis Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.6.3.1. Vaccine
Design
16.7.6.3.2. Cancer
Diagnosis and Treatment
16.7.6.3.3. Antibiotic
Drug Development
16.7.6.3.4. Production
of Antibodies
16.7.6.3.5. Mass
Spectrometry-based Applications
16.7.6.3.6. Biological
and Drug Discovery Research
16.7.6.3.7. Others
16.7.6.4. Rest
of Middle East & Africa Peptide Synthesis Market Revenue (US$ Mn) and
Forecasts, By End Users
16.7.6.4.1. Academic
and Research Institutions
16.7.6.4.2. Pharmaceutical
and Biotechnology Companies
16.7.6.4.3. Contract
Research Organizations (CROs)
16.7.6.4.4. Others
16.7.6.5. Rest
of Middle East & Africa Peptide Synthesis Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.7.6.5.1. Online
16.7.6.5.2. Offline
16.8. Key
Segment for Channeling Investments
16.8.1. By
Country
16.8.2. By
Offering
16.8.3. By
Technology
16.8.4. By
Application
16.8.5. By End
Users
16.8.6. By
Distribution Channel
17. Latin America Peptide Synthesis Market Analysis and
Forecasts, 2022 - 2030
17.1. Overview
17.1.1. Latin
America Peptide Synthesis Market Revenue (US$ Mn)
17.2. Latin
America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
17.2.1. Peptide
Synthesizers
17.2.1.1. Single
Channel Peptide Synthesizers
17.2.1.2. Multi-Channel
Peptide Synthesizers
17.2.2. Chromatography
Systems
17.2.3. HPLC
Columns
17.2.3.1. Analytical
Columns
17.2.3.2. Prep
Columns
17.2.3.3. Semi-Prep
Columns
17.2.4. Lyophilizer/Freeze
Dryers
17.2.5. Peptide
Cleavage
17.2.6. Synthesis
Reagents
17.2.6.1. Fmoc-Amino
Acids
17.2.6.2. SPPS
Resins
17.2.6.3. Coupling
Reagents for SPPS
17.2.6.4. DMB
and Isoacyl Dipeptides
17.2.6.5. Others
17.2.7. Others
17.3. Latin
America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
17.3.1. Solid-phase
Peptide Synthesis (SPPS) Technology
17.3.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
17.3.3. Hybrid
Synthesis Technology
17.4. Latin
America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
17.4.1. Vaccine
Design
17.4.2. Cancer
Diagnosis and Treatment
17.4.3. Antibiotic
Drug Development
17.4.4. Production
of Antibodies
17.4.5. Mass
Spectrometry-based Applications
17.4.6. Biological
and Drug Discovery Research
17.4.7. Others
17.5. Latin
America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
17.5.1. Academic
and Research Institutions
17.5.2. Pharmaceutical
and Biotechnology Companies
17.5.3. Contract
Research Organizations (CROs)
17.5.4. Others
17.6. Latin
America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.6.1. Online
17.6.2. Offline
17.7. Latin
America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1. Brazil
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
17.7.1.1.1. Peptide
Synthesizers
17.7.1.1.1.1. Single
Channel Peptide Synthesizers
17.7.1.1.1.2. Multi-Channel
Peptide Synthesizers
17.7.1.1.2. Chromatography
Systems
17.7.1.1.3. HPLC
Columns
17.7.1.1.3.1. Analytical
Columns
17.7.1.1.3.2. Prep
Columns
17.7.1.1.3.3. Semi-Prep
Columns
17.7.1.1.4. Lyophilizer/Freeze
Dryers
17.7.1.1.5. Peptide
Cleavage
17.7.1.1.6. Synthesis
Reagents
17.7.1.1.6.1. Fmoc-Amino
Acids
17.7.1.1.6.2. SPPS
Resins
17.7.1.1.6.3. Coupling
Reagents for SPPS
17.7.1.1.6.4. DMB
and Isoacyl Dipeptides
17.7.1.1.6.5. Others
17.7.1.1.7. Others
17.7.1.2. Brazil
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
17.7.1.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
17.7.1.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
17.7.1.2.3. Hybrid
Synthesis Technology
17.7.1.3. Brazil
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
17.7.1.3.1. Vaccine
Design
17.7.1.3.2. Cancer
Diagnosis and Treatment
17.7.1.3.3. Antibiotic
Drug Development
17.7.1.3.4. Production
of Antibodies
17.7.1.3.5. Mass
Spectrometry-based Applications
17.7.1.3.6. Biological
and Drug Discovery Research
17.7.1.3.7. Others
17.7.1.4. Brazil
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
17.7.1.4.1. Academic
and Research Institutions
17.7.1.4.2. Pharmaceutical
and Biotechnology Companies
17.7.1.4.3. Contract
Research Organizations (CROs)
17.7.1.4.4. Others
17.7.1.5. Brazil
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
17.7.1.5.1. Online
17.7.1.5.2. Offline
17.7.2. Argentina
17.7.2.1. Argentina
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Offering
17.7.2.1.1. Peptide
Synthesizers
17.7.2.1.1.1. Single
Channel Peptide Synthesizers
17.7.2.1.1.2. Multi-Channel
Peptide Synthesizers
17.7.2.1.2. Chromatography
Systems
17.7.2.1.3. HPLC
Columns
17.7.2.1.3.1. Analytical
Columns
17.7.2.1.3.2. Prep
Columns
17.7.2.1.3.3. Semi-Prep
Columns
17.7.2.1.4. Lyophilizer/Freeze
Dryers
17.7.2.1.5. Peptide
Cleavage
17.7.2.1.6. Synthesis
Reagents
17.7.2.1.6.1. Fmoc-Amino
Acids
17.7.2.1.6.2. SPPS
Resins
17.7.2.1.6.3. Coupling
Reagents for SPPS
17.7.2.1.6.4. DMB
and Isoacyl Dipeptides
17.7.2.1.6.5. Others
17.7.2.1.7. Others
17.7.2.2. Argentina
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Technology
17.7.2.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
17.7.2.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
17.7.2.2.3. Hybrid
Synthesis Technology
17.7.2.3. Argentina
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Application
17.7.2.3.1. Vaccine
Design
17.7.2.3.2. Cancer
Diagnosis and Treatment
17.7.2.3.3. Antibiotic
Drug Development
17.7.2.3.4. Production
of Antibodies
17.7.2.3.5. Mass
Spectrometry-based Applications
17.7.2.3.6. Biological
and Drug Discovery Research
17.7.2.3.7. Others
17.7.2.4. Argentina
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By End Users
17.7.2.4.1. Academic
and Research Institutions
17.7.2.4.2. Pharmaceutical
and Biotechnology Companies
17.7.2.4.3. Contract
Research Organizations (CROs)
17.7.2.4.4. Others
17.7.2.5. Argentina
Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
17.7.2.5.1. Online
17.7.2.5.2. Offline
17.7.3. Rest of
Latin America
17.7.3.1. Rest
of Latin America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Offering
17.7.3.1.1. Peptide
Synthesizers
17.7.3.1.1.1. Single
Channel Peptide Synthesizers
17.7.3.1.1.2. Multi-Channel
Peptide Synthesizers
17.7.3.1.2. Chromatography
Systems
17.7.3.1.3. HPLC
Columns
17.7.3.1.3.1. Analytical
Columns
17.7.3.1.3.2. Prep
Columns
17.7.3.1.3.3. Semi-Prep
Columns
17.7.3.1.4. Lyophilizer/Freeze
Dryers
17.7.3.1.5. Peptide
Cleavage
17.7.3.1.6. Synthesis
Reagents
17.7.3.1.6.1. Fmoc-Amino
Acids
17.7.3.1.6.2. SPPS
Resins
17.7.3.1.6.3. Coupling
Reagents for SPPS
17.7.3.1.6.4. DMB
and Isoacyl Dipeptides
17.7.3.1.6.5. Others
17.7.3.1.7. Others
17.7.3.2. Rest
of Latin America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Technology
17.7.3.2.1. Solid-phase
Peptide Synthesis (SPPS) Technology
17.7.3.2.2. Liquid-phase
Peptide Synthesis (LPPS) Technology
17.7.3.2.3. Hybrid
Synthesis Technology
17.7.3.3. Rest
of Latin America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Application
17.7.3.3.1. Vaccine
Design
17.7.3.3.2. Cancer
Diagnosis and Treatment
17.7.3.3.3. Antibiotic
Drug Development
17.7.3.3.4. Production
of Antibodies
17.7.3.3.5. Mass
Spectrometry-based Applications
17.7.3.3.6. Biological
and Drug Discovery Research
17.7.3.3.7. Others
17.7.3.4. Rest
of Latin America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
End Users
17.7.3.4.1. Academic
and Research Institutions
17.7.3.4.2. Pharmaceutical
and Biotechnology Companies
17.7.3.4.3. Contract
Research Organizations (CROs)
17.7.3.4.4. Others
17.7.3.5. Rest
of Latin America Peptide Synthesis Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.7.3.5.1. Online
17.7.3.5.2. Offline
17.8. Key
Segment for Channeling Investments
17.8.1. By
Country
17.8.2. By
Offering
17.8.3. By
Technology
17.8.4. By
Application
17.8.5. By End
Users
17.8.6. By
Distribution Channel
18. Competitive Benchmarking
18.1. Brand
Benchmarking
18.2. Market
Share Analysis, 2021
18.3. Global
Presence and Growth Strategies
18.3.1. Mergers
and Acquisitions
18.3.2. Product
Launches
18.3.3. Investments
Trends
18.3.4. R&D
Initiatives
19. Player Profiles
19.1. AAPPTec
19.1.1. Company
Details
19.1.2. Company
Overview
19.1.3. Product
Offerings
19.1.4. Key
Developments
19.1.5. Financial
Analysis
19.1.6. SWOT
Analysis
19.1.7. Business Strategies
19.2. Activotec
19.2.1. Company
Details
19.2.2. Company
Overview
19.2.3. Product
Offerings
19.2.4. Key
Developments
19.2.5. Financial
Analysis
19.2.6. SWOT
Analysis
19.2.7. Business Strategies
19.3. avenit AG (Bachem)
19.3.1. Company
Details
19.3.2. Company
Overview
19.3.3. Product
Offerings
19.3.4. Key
Developments
19.3.5. Financial
Analysis
19.3.6. SWOT
Analysis
19.3.7. Business Strategies
19.4. Biotage
19.4.1. Company
Details
19.4.2. Company
Overview
19.4.3. Product
Offerings
19.4.4. Key
Developments
19.4.5. Financial
Analysis
19.4.6. SWOT
Analysis
19.4.7. Business
Strategies
19.5. Büchi AG
19.5.1. Company
Details
19.5.2. Company
Overview
19.5.3. Product
Offerings
19.5.4. Key
Developments
19.5.5. Financial
Analysis
19.5.6. SWOT
Analysis
19.5.7. Business
Strategies
19.6. CEM
Corporation
19.6.1. Company
Details
19.6.2. Company
Overview
19.6.3. Product
Offerings
19.6.4. Key
Developments
19.6.5. Financial
Analysis
19.6.6. SWOT
Analysis
19.6.7. Business Strategies
19.7. CSBio
19.7.1. Company
Details
19.7.2. Company
Overview
19.7.3. Product
Offerings
19.7.4. Key
Developments
19.7.5. Financial
Analysis
19.7.6. SWOT
Analysis
19.7.7. Business Strategies
19.8. GenScript
19.8.1. Company
Details
19.8.2. Company
Overview
19.8.3. Product
Offerings
19.8.4. Key
Developments
19.8.5. Financial
Analysis
19.8.6. SWOT Analysis
19.8.7. Business
Strategies
19.9. Merck
KGaA
19.9.1. Company
Details
19.9.2. Company
Overview
19.9.3. Product
Offerings
19.9.4. Key
Developments
19.9.5. Financial
Analysis
19.9.6. SWOT
Analysis
19.9.7. Business Strategies
19.10. MP BIOMEDICALS
19.10.1. Company
Details
19.10.2. Company
Overview
19.10.3. Product
Offerings
19.10.4. Key
Developments
19.10.5. Financial
Analysis
19.10.6. SWOT
Analysis
19.10.7. Business Strategies
19.11. Purolite
19.11.1. Company
Details
19.11.2. Company
Overview
19.11.3. Product
Offerings
19.11.4. Key
Developments
19.11.5. Financial
Analysis
19.11.6. SWOT
Analysis
19.11.7. Business Strategies
19.12. Thermo
Fisher Scientific
19.12.1. Company
Details
19.12.2. Company
Overview
19.12.3. Product
Offerings
19.12.4. Key Developments
19.12.5. Financial
Analysis
19.12.6. SWOT
Analysis
19.12.7. Business
Strategies
19.13. Other
Market Participant
20. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.